悦达投资：10月24日召开董事会会议

Company Summary - Yueda Investment (SH 600805) announced on October 24 that its 12th eighth board meeting was held via communication voting, where the proposal for the profit distribution plan for Q3 2025 was reviewed [1] - For the first half of 2025, Yueda Investment's revenue composition was as follows: manufacturing accounted for 73.79%, services for 9.51%, other businesses for 7.51%, electricity and heat production and supply for 7.43%, and commodity circulation for 1.76% [1] - As of the report date, Yueda Investment's market capitalization was 4.5 billion yuan [1] Industry Insights - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion USD this year [1] - Despite the booming secondary market for biomedicine, fundraising in the primary market is facing challenges, as discussed in an interview with Lu Gang, a partner at Chuangdong Investment [1]